IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Disc Medicine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$78.93+22.09 (+38.86%)
Close on Oct 19, 2026
- Market cap
- $3.05B
- P/E (TTM)
- –
- Dividend yield
- –
Disc Medicine statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Market Cap | $3.03B | $197.05M |
| Enterprise Value | $2.31B | $106.56M |
| PB Ratio | 4.70 | 2.14 |
| P/TBV Ratio | 4.70 | 2.46 |
Income (trailing twelve months)
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Operating Income | -$269.27M | -$21.44M |
| Pretax Income | -$245.58M | -$14.45M |
| Net Income | -$245.89M | -$22.46M |
| EBITDA | -$268.91M | -$16.91M |
| EPS (Diluted) | -$6.57 | -$0.83 |
Returns
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Return on Equity (ROE) | -39.1% | -53.1% |
| Return on Assets (ROA) | -35.1% | -41.0% |
| Return on Capital Employed (ROCE) | -38.2% | -37.8% |
Balance sheet
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $717.70M | $62.42M |
| Net Cash (Debt) | $717.70M | $15.68M |
| Net Cash Per Share | $18.69 | $0.65 |
| Equity (Book Value) | $644.16M | $48.79M |
| Book Value Per Share | $16.78 | $1.36 |
| Tangible Book Value | $644.16M | $23.06M |
| Working Capital | $702.40M | $75.77M |
Financial position
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Current Ratio | 24.14 | 3.30 |
| Quick Ratio | 23.64 | 2.39 |
| Interest Coverage | -75.81 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Operating Cash Flow | -$197.54M | -$12.35M |
| Capital Expenditures | -$46.00K | -$1.06M |
| Free Cash Flow | -$197.58M | -$20.28M |
| FCF Per Share | -$5.15 | -$0.41 |
Efficiency
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Profits Per Employee | -$1.59M | -$732.08K |
| Employee Count | 155 | 73 |
Dividends and yields
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Earnings Yield | -8.11% | -21.2% |
| FCF Yield | -6.52% | -7.64% |
Shares
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Shares Outstanding | 38,392,800 | 59,128,900 |
| Shares Change (YoY) | 16.9% | 11.1% |
| Shares Change (QoQ) | 0.41% | 0.54% |
| Float | 26,683,700 | 48,744,500 |
| Shares Held by Insiders | 30.5% | 11.8% |
| Shares Held by Institutions | 112.4% | 59.4% |
Taxes
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Income Tax | $310.00K | $91.50K |
Scores
| Measure | Disc Medicine | Industry median |
|---|---|---|
| Altman Z-Score | 18.73 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Disc Medicine's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.